title: Fluoroquinolones in the treatment of severe community-acquired.
authors.affiliation: Microbiology Department, Old Medical School, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust. Mark.wilcox@leedsth.nhs.uk
authors.forename: Mark H
authors.initials: MH
authors.lastname: Wilcox
authors.forename: Roger
authors.initials: R
authors.lastname: Finch
authors.forename: Duncan
authors.initials: D
authors.lastname: Wyncoll
authors.forename: Kate
authors.initials: K
authors.lastname: Gould
authors.forename: Philip
authors.initials: P
authors.lastname: Howard
mesh_terms: D016360:Clostridioides difficile; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000401:mortality; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced; D024841:Fluoroquinolones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D019983:Guideline Adherence; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000401:mortality; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index; D006113:United Kingdom
chemical_list: D024841:Fluoroquinolones